Bakuchiol: The Science Behind the Retinol Alternative

The Quick Answer

Bakuchiol is a meroterpene phenol derived from the seeds and leaves of Psoralea corylifolia — a plant used in Ayurvedic and traditional Chinese medicine for thousands of years. In modern skincare, it is significant because a randomised controlled trial published in the British Journal of Dermatology in 2018 found that 0.5% bakuchiol twice daily performed comparably to 0.5% retinol once daily for wrinkle reduction, pigmentation improvement, and elasticity — with significantly less irritation, dryness, and photosensitivity.

Is Bakuchiol Really Comparable to Retinol?

The 2018 Dhaliwal et al. study in the British Journal of Dermatology is the key reference here. In this 12-week double-blind randomised trial, 44 subjects used either 0.5% bakuchiol twice daily or 0.5% retinol once daily. The results were:

• Comparable reduction in wrinkle depth and surface area for both groups
• Comparable improvement in skin elasticity and firmness
• Comparable reduction in hyperpigmentation
• Significantly lower incidence of stinging, scaling, and photosensitivity in the bakuchiol group

This does not mean bakuchiol is equally potent to retinol at all concentrations — rather, at 0.5%, twice-daily bakuchiol matched once-daily 0.5% retinol. Higher retinol concentrations (0.3–1%) have not been directly compared to bakuchiol in published trials. The honest interpretation is: bakuchiol performs in a similar ballpark to moderate retinol, with substantially better tolerability.

How Does Bakuchiol Work?

Bakuchiol's mechanism is distinct from retinol. It does not convert to retinoic acid — it is not a retinoid at all chemically. Instead, research has shown it upregulates some of the same genes that retinoic acid does, including genes involved in collagen synthesis, and downregulates matrix metalloproteinases (the enzymes that degrade collagen). It also has antioxidant and anti-inflammatory properties that retinoids lack.

Because it does not work through retinoic acid receptors, it avoids the mechanisms responsible for retinoid side effects: irritation, dryness, and photosensitivity. This is what makes it genuinely different from a retinol ester (like retinyl palmitate) — it is not a weaker version of retinol, it is a different molecule that achieves some of the same downstream effects through alternative pathways.

Key Advantages Over Retinol

• No photosensitivity: Can be used morning and evening. No increased UV sensitivity. SPF is still recommended (always), but not because of bakuchiol.
• No "adjustment period": No retinol uglies, no peeling phase, no need to start once a week and build up slowly
• Pregnancy safety: Retinoids are contraindicated in pregnancy due to teratogenicity concerns. Bakuchiol has no such evidence and is widely considered a safe alternative for pregnant skin — though as with all ingredients, consulting a healthcare provider is recommended
• Compatible with AHAs: Unlike retinol, bakuchiol can be used on the same night as acid exfoliants without dramatically increasing irritation risk
• Suitable for sensitive and rosacea-prone skin: The irritation profile is comparable to a standard moisturiser

Limitations of Bakuchiol

• Less potency data at concentrations above 0.5% compared to the retinol literature
• Generally more expensive than retinol at equivalent formulation quality
• For maximum anti-aging efficacy in resilient skin, high-dose retinol or retinaldehyde still has more total clinical evidence
• Results may be slower for individuals who can tolerate retinol without issue

Who Should Use Bakuchiol?

• Sensitive and reactive skin: Get retinol-comparable anti-aging benefits without the barrier disruption
• Pregnant or breastfeeding: One of the only evidence-backed anti-aging options considered safe (consult your doctor)
• Retinol beginners who are nervous: Start with bakuchiol, observe the results, then decide if you need to escalate to retinol
• Rosacea-prone skin: Retinoids are often too irritating; bakuchiol provides anti-aging benefit without triggering flares
• Anyone who has failed retinol due to irritation: Bakuchiol is often a successful alternative for those who cannot tolerate any concentration of retinol

How to Use Bakuchiol

Use at 0.5–1% concentration, morning and evening, after cleansing and before moisturiser. It does not require the gradual introduction that retinol does — you can start using it daily from the outset. It is compatible with all other actives and does not require any specific timing restrictions.

The Bottom Line

Bakuchiol is not a marketing gimmick. The clinical evidence for it is real, peer-reviewed, and published in a reputable dermatology journal. For sensitive, pregnant, or reactive skin, it is an excellent primary anti-aging active. For everyone else, it can serve as a gentler alternative to retinol or as a complementary AM anti-aging ingredient (while retinol runs PM). The research does not support it replacing high-potency retinoids for those who can tolerate them — but for a very large portion of the population, it is an honest, well-evidenced choice.

The Gene Expression Evidence: How Bakuchiol Mimics Retinol

The claim that bakuchiol is a "retinol alternative" requires a biological mechanism — because bakuchiol is not a retinoid, does not bind retinoid receptors, and is chemically unrelated to vitamin A. The mechanism that makes the comparison legitimate is at the gene expression level, and it is more specific than most summaries suggest.

Retinoic acid (the active form that retinol converts to) works by binding RAR (retinoic acid receptor) and RXR (retinoid X receptor) nuclear receptors, which then act as transcription factors — altering which genes are expressed in the skin cell. The genes upregulated by this receptor activation include genes for collagen type I and III synthesis, genes for hyaluronic acid production, and genes that inhibit matrix metalloproteinases (the enzymes that degrade existing collagen).

Research by Chaudhuri et al., published in the International Journal of Cosmetic Science, used gene expression profiling to show that bakuchiol upregulates many of the same genes that retinoic acid does — including several collagen synthesis genes and MMP-inhibiting genes — without binding to retinoid receptors. The proposed mechanism is that bakuchiol acts through a different receptor pathway (potentially PPAR receptors, which are also involved in skin lipid metabolism and inflammation) that converges on some of the same downstream gene targets as retinoid signalling.

This gene-level overlap is what gives bakuchiol its retinol-like clinical outcomes. It is not a retinoid mimicry at the receptor level — it is functional convergence at the level of gene expression outcomes. This distinction matters because it explains why bakuchiol avoids retinoid side effects (it does not trigger the same receptor-mediated irritation pathways) while still producing some of the same skin quality improvements.

Interpreting the Clinical Evidence Accurately

The Dhaliwal et al. 2018 study in the British Journal of Dermatology is genuinely well-conducted and deserves its prominence in bakuchiol discussions — but its findings are also more nuanced than the "bakuchiol equals retinol" summary often presented.

Key details of the study design: 44 subjects (a small but adequate sample for a proof-of-concept trial), twelve weeks duration, 0.5% bakuchiol twice daily versus 0.5% retinol once daily. The study did not compare bakuchiol to higher retinol concentrations (0.3–1%) that experienced users often progress to. It did not include a placebo arm, making it harder to isolate treatment effect from natural skin variation. It was not industry-funded — an important credibility point — and was published in a peer-reviewed journal with appropriate methodology.

The outcomes showing statistical equivalence between groups for wrinkle depth, surface area, hyperpigmentation, and elasticity at twelve weeks are robust findings for the comparison it made. The significantly lower irritation, scaling, and photosensitivity in the bakuchiol group is one of the clearest findings in the study.

What the study does not establish: that bakuchiol is equivalent to 1% retinol, or to retinaldehyde, or to prescription tretinoin. The comparison is specifically to 0.5% retinol at the frequencies studied. For people who have built tolerance to higher retinol concentrations and want maximum anti-ageing efficacy, the evidence does not support switching to bakuchiol as a step up. For those at the 0.5% retinol level or below, the evidence for bakuchiol as a genuinely comparable alternative with better tolerability is solid.

Using Bakuchiol and Retinol Together

One of the underexplored aspects of bakuchiol is that its AM-compatible, AHA-compatible, non-photosensitising profile makes it an excellent complement to retinol rather than simply a replacement for it. The two can be used in the same routine to address different aspects of the skin renewal and anti-ageing goal.

A combined approach: retinol (or retinaldehyde) in the PM routine, three to five nights per week, addressing the receptor-mediated cell renewal and collagen stimulation that retinoids specifically achieve. Bakuchiol in the AM routine, daily, providing antioxidant support, additional collagen gene expression stimulus, and anti-inflammatory activity during the day without any photosensitivity risk. This combination gives the skin two different pathways to improved collagen production and texture simultaneously — retinoid receptor-mediated PM and bakuchiol-mediated AM — potentially producing faster results than either alone.

For people in the retinol adaptation period who are still building tolerance, bakuchiol in the AM provides continuing anti-ageing stimulus on the nights and days when retinol is not used, preventing the gaps in active treatment that a slow retinol introduction schedule creates. This is particularly useful in the first three to four months of retinol use, when the frequency is still building toward nightly.

Common Questions About Bakuchiol

Is bakuchiol truly safe in pregnancy?

Bakuchiol has no known teratogenic risk and is not a retinoid — the mechanism of concern for retinoids in pregnancy (systemic vitamin A excess causing birth defects) does not apply to bakuchiol. Multiple dermatologists and midwife-facing resources list it as a safe retinol alternative during pregnancy. However, the clinical safety data specific to pregnancy is limited (no formal teratogenicity studies have been conducted, as is standard for cosmetic ingredients), so "no known risk" is a more accurate characterisation than "proven safe." Consulting with an obstetrician or midwife for individual guidance remains the appropriate approach, as it does for all skincare decisions during pregnancy.

Does bakuchiol have a shelf life concern like retinol?

Bakuchiol is significantly more stable than retinol — it does not oxidise rapidly on exposure to light and air and does not require the same opaque, airless packaging that retinol demands. This is a practical formulation advantage that contributes to the wider range of product formats bakuchiol appears in (clear bottles, dropper dispensers) that would be unsuitable for retinol. Standard cosmetic shelf life and storage conditions (cool, away from direct sunlight) are appropriate for bakuchiol-containing products.

Can you use bakuchiol with acids on the same night?

Yes — this is one of bakuchiol's genuine practical advantages over retinol. Because bakuchiol does not work through retinoid receptor activation, it does not create the compounded cellular disruption and pH conflict that makes retinol and AHA combination on the same night inadvisable. Bakuchiol and a gentle AHA (lactic acid 5–10%) on the same evening is tolerated by most skin types. This makes bakuchiol useful for people who want the simplicity of fewer active-management scheduling constraints — one PM product that works alongside their existing acid nights rather than requiring its own dedicated schedule.